ATE406093T1 - Verfahren und zusammensetzungen für die pharmakologische und toxikologische auswertung von testsubstanzen - Google Patents
Verfahren und zusammensetzungen für die pharmakologische und toxikologische auswertung von testsubstanzenInfo
- Publication number
- ATE406093T1 ATE406093T1 AT03744148T AT03744148T ATE406093T1 AT E406093 T1 ATE406093 T1 AT E406093T1 AT 03744148 T AT03744148 T AT 03744148T AT 03744148 T AT03744148 T AT 03744148T AT E406093 T1 ATE406093 T1 AT E406093T1
- Authority
- AT
- Austria
- Prior art keywords
- pharmacological
- compositions
- methods
- test substances
- toxicological evaluation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/142—Toxicological screening, e.g. expression profiles which identify toxicity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36189002P | 2002-03-05 | 2002-03-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE406093T1 true ATE406093T1 (de) | 2008-09-15 |
Family
ID=27805091
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03744148T ATE406093T1 (de) | 2002-03-05 | 2003-03-04 | Verfahren und zusammensetzungen für die pharmakologische und toxikologische auswertung von testsubstanzen |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20030237103A1 (de) |
| EP (1) | EP1487261B1 (de) |
| JP (1) | JP2005520503A (de) |
| AT (1) | ATE406093T1 (de) |
| AU (1) | AU2003216489A1 (de) |
| DE (1) | DE60323214D1 (de) |
| DK (1) | DK1487261T3 (de) |
| WO (1) | WO2003075838A2 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1546162B1 (de) | 2002-09-20 | 2011-06-22 | Promega Corporation | Auf lumineszenz basierende verfahren und sonden zur messung der cytochrom-p450-aktivität |
| EP2778234B1 (de) | 2005-05-31 | 2017-09-27 | Promega Corporation | Luminogene und fluorogene verbindungen und verfahren für den nachweis von molekülen oder leiden |
| US8612176B2 (en) * | 2007-01-26 | 2013-12-17 | Auburn University | Nominal population metric: clustering of nominal application attributes |
| US20080228700A1 (en) | 2007-03-16 | 2008-09-18 | Expanse Networks, Inc. | Attribute Combination Discovery |
| WO2010021686A1 (en) * | 2008-08-18 | 2010-02-25 | Promega Corporation | Luminogenic compounds and methods to detect cytochrome p450 3a enzymes |
| EP2370929A4 (de) | 2008-12-31 | 2016-11-23 | 23Andme Inc | Suche nach verwandten in einer datenbank |
| US9790537B2 (en) | 2014-01-29 | 2017-10-17 | Promega Corporation | Quinone-masked probes as labeling reagents for cell uptake measurements |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1992007095A1 (en) * | 1990-10-15 | 1992-04-30 | Stratagene | Arbitrarily primed polymerase chain reaction method for fingerprinting genomes |
| US5580728A (en) * | 1994-06-17 | 1996-12-03 | Perlin; Mark W. | Method and system for genotyping |
| WO1999040226A2 (en) * | 1998-02-04 | 1999-08-12 | Perkin-Elmer Corporation | Determination of a genotype of an amplification product at multiple allelic sites |
| US6534574B1 (en) * | 2001-03-24 | 2003-03-18 | Milliken & Company | Highly nucleated thermoplastic articles |
| US6465551B1 (en) * | 2001-03-24 | 2002-10-15 | Milliken & Company | Bicyclo[2.2.1]heptane dicarboxylate salts as polyolefin nucleators |
-
2003
- 2003-03-04 EP EP03744148A patent/EP1487261B1/de not_active Expired - Lifetime
- 2003-03-04 WO PCT/US2003/006421 patent/WO2003075838A2/en not_active Ceased
- 2003-03-04 AT AT03744148T patent/ATE406093T1/de not_active IP Right Cessation
- 2003-03-04 JP JP2003574114A patent/JP2005520503A/ja not_active Ceased
- 2003-03-04 DE DE60323214T patent/DE60323214D1/de not_active Expired - Fee Related
- 2003-03-04 AU AU2003216489A patent/AU2003216489A1/en not_active Abandoned
- 2003-03-04 US US10/379,217 patent/US20030237103A1/en not_active Abandoned
- 2003-03-04 DK DK03744148T patent/DK1487261T3/da active
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003075838A3 (en) | 2003-12-04 |
| US20030237103A1 (en) | 2003-12-25 |
| EP1487261A2 (de) | 2004-12-22 |
| AU2003216489A1 (en) | 2003-09-22 |
| JP2005520503A (ja) | 2005-07-14 |
| AU2003216489A8 (en) | 2003-09-22 |
| WO2003075838A2 (en) | 2003-09-18 |
| EP1487261B1 (de) | 2008-08-27 |
| DE60323214D1 (de) | 2008-10-09 |
| EP1487261A4 (de) | 2005-04-13 |
| DK1487261T3 (da) | 2008-11-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE513911T1 (de) | Verfahren und zusammensetzungen für rna- interferenz | |
| DE60118660D1 (de) | Zusammensetzungen und Verfahren zum Nachweis von Mais-Transformante PV-ZMGT32 (NK603) | |
| DE60207514D1 (de) | Zusammensetzungen und Verfahren zum Nachweis und zur Behandlung von mit Chemokinrezeptoren verbundenen Krankheiten | |
| IL177495A0 (en) | Methods of isolating and identifying cells using signaling probes | |
| ATE516497T1 (de) | Screening für funktionshomologien | |
| ATE444377T1 (de) | Nukleinsäurecharakterisierung | |
| DE60318642D1 (de) | Multi-Test-Analyse von Echzeit-Nukleinsäureamplifikationen | |
| DE602004030372D1 (de) | Verfahren zur Bestimmung des relativen genetischen Risikos für Autismus | |
| WO2008005290A3 (en) | Methods for testing anti-thrombotic agents | |
| ATE336591T1 (de) | Nachweisverfahren für kurze sequenzvarianten | |
| DE60335812D1 (de) | Biosensor und verfahren zu seiner herstellung | |
| DE60323214D1 (de) | Verfahren und zusammensetzungen für die pharmakologische und toxikologische auswertung von testsubstanzen | |
| DK1038033T3 (da) | Assay og kit med stor kapacitet baseret på anvendelsen af nuclease-beskyttelsesfragmenter | |
| WO2001064949A3 (en) | Diagnostics and therapeutics for glaucoma | |
| ATE390485T1 (de) | Irak-4 zusammensetzungen und deren verwendungen | |
| CY1110138T1 (el) | Προσδιορισμος υψηλης διεκπεραιωτικοτητας της δραστικοτητας lp-pla2 | |
| WO2001087055A3 (en) | New screening tool for analyzing the behavior of laboratory animals | |
| ATE474049T1 (de) | Nukleinsäuren aus monocyten und verwandte zusammensetzungen und verfahren | |
| ATE420162T1 (de) | Verfahren und zusammensetzungen zum targeting sekretorischer lysosomen | |
| ATE242781T1 (de) | Verfahren, kit und dna-sonden zum nachweis einer pilz-spezies in klinischem material | |
| TR200200208T2 (tr) | C.Albicans esas genleri ve antimikotik maddelerin taranması yöntemi | |
| EP1483962A3 (de) | Transgenes Tiermodel für Glyt1 Funktion | |
| ATA11722001A (de) | Test-kit für den nachweis der bakteriellen gene slt1, slt2 und rfbe | |
| PT1537210E (pt) | Inibicao de oliconucleotidos decoy de expressao cd-40 | |
| ATE359520T1 (de) | Verfahren und kompositionen für opsonophagozyttests |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |